Cargando…
Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital
PURPOSE: The purpose of this drug utilization study was to describe the use of rivaroxaban in Germany during a time period in which approval was limited to the prevention of venous thromboembolism following hip or knee replacement. Additionally, we explored the feasibility of reconstructing inpatien...
Autores principales: | Jobski, Kathrin, Enders, Dirk, Amann, Ute, Suzart, Kiliana, Wallander, Mari-Ann, Schink, Tania, Garbe, Edeltraut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088992/ https://www.ncbi.nlm.nih.gov/pubmed/24858823 http://dx.doi.org/10.1007/s00228-014-1697-7 |
Ejemplares similares
-
Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018
por: Rückert-Eheberg, Ina-Maria, et al.
Publicado: (2021) -
Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria
por: Verdoorn, Sanne, et al.
Publicado: (2015) -
The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany
por: Grimmsmann, Thomas, et al.
Publicado: (2020) -
Pain severity and analgesics use in the community-dwelling older population: a drug utilization study from Germany
por: Nguyen, Thi Ngoc Mai, et al.
Publicado: (2020) -
Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase
por: Zhang, Qingxia, et al.
Publicado: (2022)